(Q61957273)

English

Phase I Study of CS-7017 and Bexarotene

clinical trial

Statements

A Phase I Study of a Combination of the Proteosome Proliferator-Activated Receptor Gamma Agonist, CS-7017 and the Retinoid X Receptor Agonist, Bexarotene (English)
0 references
December 2011
0 references
December 2016
0 references
9
0 references
0 references
0 references
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit